ANIMATION

EGFRvIII(+) Glioblastoma

Share this article with:

Glioblastoma multiforme is considered one of the most aggressive cancers, with an estimated 5-year survival rate of less than 5%. It has been found that approximately 30% of glioblastoma tumors selectively express the EGFRvIII variant receptor, the activity of which contributes to tumor growth, resistance to apoptosis, and tumor angiogenesis. The persistence of EGFRvIII on glioblastoma cells suggest it may be a viable candidate for more targeted therapeutic approaches.

Share It:
Contact XVIVO

Client


Celldex

XVIVO is top notch! I work with a lot of vendors on behalf of my clients and XVIVO exceeding my expectations every time. Not only was the work outstanding, the service was as well. Even when things got crazy, and they did several times, XVIVO delivered with a positive, can do it attitude – making my life and direct contact with the client much easier.

Account Director, Palio Communications